Volition presents study data at ASCO GI 2022 on circulating

AUSTIN, Texas, Jan. 20, 2022 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the results of two large scale clinical studies, which show that the

Related Keywords

National Taiwan University , T Ai Pei , Taiwan , Japan , Tokyo , Texas , United States , Singapore , Belgium , National Taiwan University Hospital , California , South Korea , London , City Of , United Kingdom , Han , Taiwanese , Mo Chiu , Marielle Herzog , Department Of Internal Medicine , Volitionrx Limited , Linkedin , Twitter , Exchange Commission , Youtube , Million Taiwanese Screening Program , Securities Exchange , Facebook , Eiken Chemical Co Ltd , Fecal Immunochemical Test , Professor Han Mo Chiu , Development Director , Internal Medicine , Cancers Symposium , World Health Organization International Agency , One Million Taiwanese Screening , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Tncen , Mex Vnrx , West Southwest , United States Of America , North America ,